Understanding the Mechanisms of TDP-43 Function
了解 TDP-43 功能的机制
基本信息
- 批准号:8613510
- 负责人:
- 金额:$ 23.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-02-15 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAmyotrophic Lateral SclerosisAntibodiesBacterial Artificial ChromosomesBindingBiochemicalBiologicalBiotinC9ORF72Cell Culture SystemCell NucleusCellsCircular DichroismCo-ImmunoprecipitationsCommunitiesDNADNA SequenceDNA-Binding ProteinsDataDiseaseEmbryoExhibitsFrontotemporal Lobar DegenerationsGeneticGoalsHumanImmunochemistryImmunoprecipitationIn VitroKnockout MiceLeadLightLinkMediatingMessenger RNAMusMutant Strains MiceMutationN-terminalNerve DegenerationNeurodegenerative DisordersNeuronsNuclearPathogenesisPatientsPhosphorylationPhosphorylation SitePhysiologicalProgranulinProteinsRNARecombinantsResearchRoleSamplingSecondary Protein StructureSiteStructureTestingTherapeuticToxic effectTransgenic MiceTransgenic OrganismsTyrosineTyrosine PhosphorylationUbiquitinUbiquitinationUreaWestern Blottingaspartyl-arginyl-valyl-tyrosyl-isoleucyl-histidyl-prolyl-phenylalanyl-histidyl-leucyl-valyl-isoleucyl-histidinebrain cellin vivoin vivo Modelinsightloss of functionmouse modelnew therapeutic targetnovelprotein TDP-43public health relevanceresearch studysortilin
项目摘要
DESCRIPTION (provided by applicant): TDP-43 is the principal component of ubiquitin-positive inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-TDP) and amyotrophic lateral sclerosis (ALS). Recently, we discovered that TDP-43 is hyper-phosphorylated at tyrosine-4 in disease and pseudo-phosphorylation of tyrosine-4 (TDP- 43Y4D) impairs TDP-43 biological activities. Therefore, our data provide a direct link between TDP-43 phosphorylation and loss of TDP-43 function, which is believed to mediate toxicity and neurodegeneration. We hypothesize that hyper-phosphorylation of TDP-43 at tyrosine-4 contributes to disease pathogenesis by reducing TDP-43 biological activities. Specifically, we will use a combination of in vitro and in vivo models to 1) investigate pathological significance o TDP-43 phosphorylation at tyrosine-4 in disease pathogenesis; 2) investigate the potential mechanisms through which phosphorylation at tyrosine-4 impair TDP-43 biological activities; 3) generate novel bacterial artificial chromosome (BAC) transgenic mouse model expressing human TDP-43Y4D to investigate whether TDP-43Y4D result in loss-of function in vivo. Successful completion of our novel study will undoubtedly enhance the scientific community's understanding of the TDP-43 N-terminus' role, particularly of its N-terminal phosphorylation at tyrosine-4, in disease pathogenesis, might also provide therapeutic approaches. .
描述(由申请人提供):TDP-43是额颞叶变性伴泛素阳性包涵体(FTLD-TDP)和肌萎缩侧索硬化症(ALS)中泛素阳性包涵体的主要成分。最近,我们发现在疾病中 TDP-43 在 4 号酪氨酸处过度磷酸化,并且 4 号酪氨酸 (TDP-43Y4D) 的假磷酸化会损害 TDP-43 的生物活性。因此,我们的数据提供了 TDP-43 磷酸化和 TDP-43 功能丧失之间的直接联系,TDP-43 功能被认为介导毒性和神经退行性变。我们假设 TDP-43 在酪氨酸 4 处的过度磷酸化通过降低 TDP-43 生物活性来促进疾病发病机制。具体来说,我们将结合使用体外和体内模型来 1) 研究 TDP-43 酪氨酸 4 磷酸化在疾病发病机制中的病理意义; 2) 研究酪氨酸4磷酸化损害TDP-43生物活性的潜在机制; 3) 生成表达人TDP-43Y4D的新型细菌人工染色体(BAC)转基因小鼠模型,以研究TDP-43Y4D是否导致体内功能丧失。我们新研究的成功完成无疑将增强科学界对 TDP-43 N 末端作用的理解,特别是其 N 末端酪氨酸 4 的磷酸化在疾病发病机制中的作用,也可能提供治疗方法。 。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
人TDP-43转基因小鼠模型的病理表型与小鼠Tdp-43的下调无关。
- DOI:10.1371/journal.pone.0069864
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Xu,Ya-Fei;Prudencio,Mercedes;Hubbard,JaimeM;Tong,Jimei;Whitelaw,EnaC;Jansen-West,Karen;Stetler,Caroline;Cao,Xiangkun;Song,John;Zhang,Yong-Jie
- 通讯作者:Zhang,Yong-Jie
The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo.
- DOI:10.1016/j.brainres.2016.04.069
- 发表时间:2016-09-15
- 期刊:
- 影响因子:2.9
- 作者:Sasaguri, Hiroki;Chew, Jeannie;Xu, Ya-Fei;Gendron, Tania F.;Garrett, Aliesha;Lee, Chris W.;Jansen-West, Karen;Bauer, Peter O.;Perkerson, Emilie A.;Tong, Jimei;Stetler, Caroline;Zhang, Yong-Jie
- 通讯作者:Zhang, Yong-Jie
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John David Fryer其他文献
John David Fryer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John David Fryer', 18)}}的其他基金
Novel genetic modifiers of C9orf72 and Tau toxicity
C9orf72 和 Tau 毒性的新型遗传修饰剂
- 批准号:
10084641 - 财政年份:2019
- 资助金额:
$ 23.24万 - 项目类别:
Development and characterization of a novel Clusterin mouse model
新型 Clusterin 小鼠模型的开发和表征
- 批准号:
9065478 - 财政年份:2015
- 资助金额:
$ 23.24万 - 项目类别:
The role of Clusterin in cerebral amyloid angiopathy
Clusterin 在脑淀粉样血管病中的作用
- 批准号:
9765415 - 财政年份:2015
- 资助金额:
$ 23.24万 - 项目类别:
The role of Clusterin in cerebral amyloid angiopathy
Clusterin 在脑淀粉样血管病中的作用
- 批准号:
9147489 - 财政年份:2015
- 资助金额:
$ 23.24万 - 项目类别:
Understanding the Mechanisms of TDP-43 Function
了解 TDP-43 功能的机制
- 批准号:
8507420 - 财政年份:2013
- 资助金额:
$ 23.24万 - 项目类别:
The role of capicua in spinocerebellar ataxia type 1
Capicua 在 1 型脊髓小脑共济失调中的作用
- 批准号:
7113397 - 财政年份:2006
- 资助金额:
$ 23.24万 - 项目类别:
The role of capicua in spinocerebellar ataxia type 1
Capicua 在 1 型脊髓小脑共济失调中的作用
- 批准号:
7243457 - 财政年份:2006
- 资助金额:
$ 23.24万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Fellowship